Nara PL - Search Results

1

Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates.

Hosmalin A, Nara PL, Zweig M, Lerche NW, Cease KB, Gard EA, Markham PD, Putney SD, Daniel MD, Desrosiers RC, et al. Hosmalin A, et al. Among authors: nara pl. J Immunol. 1991 Mar 1;146(5):1667-73. J Immunol. 1991. PMID: 1704401

2

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

Pyle SW, Morein B, Bess JW Jr, Akerblom L, Nara PL, Nigida SM Jr, Lerche NW, Robey WG, Fischinger PJ, Arthur LO. Pyle SW, et al. Among authors: nara pl. Vaccine. 1989 Oct;7(5):465-73. doi: 10.1016/0264-410x(89)90164-3. Vaccine. 1989. PMID: 2554608

3

Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.

Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA. Ahlers JD, et al. Among authors: nara pl. J Immunol. 1993 Jun 15;150(12):5647-65. J Immunol. 1993. PMID: 8515081

4

Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.

Profy AT, Salinas PA, Eckler LI, Dunlop NM, Nara PL, Putney SD. Profy AT, et al. Among authors: nara pl. J Immunol. 1990 Jun 15;144(12):4641-7. J Immunol. 1990. PMID: 1693639

5

Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.

Krohn K, Robey WG, Putney S, Arthur L, Nara P, Fischinger P, Gallo RC, Wong-Staal F, Ranki A. Krohn K, et al. Proc Natl Acad Sci U S A. 1987 Jul;84(14):4994-8. doi: 10.1073/pnas.84.14.4994. Proc Natl Acad Sci U S A. 1987. PMID: 2440037 Free PMC article.

6

HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.

Akerblom L, Nara P, Dunlop N, Putney S, Morein B. Akerblom L, et al. Biotechnol Ther. 1993;4(3-4):145-61. Biotechnol Ther. 1993. PMID: 8292967

7

Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies.

Zweig M, Showalter SD, Bladen SV, Gilden RV, Arthur LO, Robey WG, Nara PL, Fischinger PJ. Zweig M, et al. Among authors: nara pl. AIDS Res Hum Retroviruses. 1988 Feb;4(1):51-62. doi: 10.1089/aid.1988.4.51. AIDS Res Hum Retroviruses. 1988. PMID: 3259140

8

Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope.

Garrity RR, Rimmelzwaan G, Minassian A, Tsai WP, Lin G, de Jong JJ, Goudsmit J, Nara PL. Garrity RR, et al. Among authors: nara pl. J Immunol. 1997 Jul 1;159(1):279-89. J Immunol. 1997. PMID: 9200464

9

Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes.

Ahlers JD, Dunlop N, Alling DW, Nara PL, Berzofsky JA. Ahlers JD, et al. Among authors: nara pl. J Immunol. 1997 Apr 15;158(8):3947-58. J Immunol. 1997. PMID: 9103465

10

Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization.

Ahlers JD, Dunlop N, Pendleton CD, Newman M, Nara PL, Berzofsky JA. Ahlers JD, et al. Among authors: nara pl. AIDS Res Hum Retroviruses. 1996 Mar 1;12(4):259-72. doi: 10.1089/aid.1996.12.259. AIDS Res Hum Retroviruses. 1996. PMID: 8906986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters